JavaScript is disabled. Please enable to continue!

Mobile search icon
EurofinsUS.com >> Agrigenomics >> Our Company

Worldwide Excellence in Bio-analytical Testing

Sidebar Image

Company Overview

Eurofins Scientific is an international life sciences company which provides a unique range of analytical testing services to clients across multiple industries. The Group believes it is the world leader in food, environment and pharmaceutical products testing, as well as one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA.

Short History

Eurofins Scientific was founded in 1987 with 10 employees to market the SNIF-NMRâ technology, a patented analytical method used to verify the origin and purity of several types of food and beverages and identify sophisticated fraud not detectable by other methods.

Today the Eurofins Group is a leading provider of analytical services with :

  • an international network of over 800 laboratories across 50 countries in Europe, North and South America and Asia-Pacific
  • over 50,000 staff
  • a portfolio of over 200,000 validated analytical methods
  • more than 150 million assays performed each year to establish the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products, as well as carry out human diagnostic services.

Eurofins is one of the fastest growing listed European companies. Since its IPO on the French stock exchange in 1997, Eurofins' sales have increased by 37% each year (in compound average) to over EUR 2.97 billion in 2018.

Between the Initial Public Offering on 24 October 1997 (€1.83) and 31 March 2016 (€322.35), Eurofins' share price has multiplied by 176x, an annual average increase of 31% (against 3% for the SBF 120, 2% for the CAC 40 and 6% for the Nasdaq over the same period).

Comprehensive services and unmatched expertise

Eurofins believes it is a worldwide leader in its field. The Group offers a portfolio of more than 130,000 validated analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products. Through research and development and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.

A commitment to top quality

The Eurofins Group is committed to provide the highest quality services, accurate results in time and expert advice by its highly qualified staff. The reliability and accuracy of its data help customers make adequate decisions on risks and meet their increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.

Permanent innovation and support by the market leader

Few testing laboratories can combine the level of expertise, technological leadership, attention to quality and customer service that have made Eurofins the global leader in many of the fields where it is active. Large investments in innovation, technology, IT and logistics and very large sample volumes ensure that customers enjoy high standards of quality at reasonable prices.